Intermountain Ventures

Investor type Corporate Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 7
Rounds per year 2.50
Lead investments 1
Key employees Soon

Areas of investment

  • Health Care
  • Pharmaceutical
  • Biotechnology
  • Bioinformatics
  • Information Technology
Summary

Intermountain Ventures appeared to be a CVC structure as part of the corporation.

The important activity for fund was in 2019. The fund is generally included in less than 2 deals every year.

The typical case for the fund is to invest in rounds with 1 participant. Despite the Intermountain Ventures, startups are often financed by U.S. Venture Partners (USVP), Norwest Venture Partners, Sanofi-Genzyme BioVentures.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Health Care. Among the various public portfolio startups of the fund, we may underline Omada Health

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Intermountain Ventures:
Typical Co-investors
Intermountain Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Intermountain Ventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aegon Industrial Fund Management Co. -
Bonjour Holdings China, Hong Kong, New Territories
Choice Capital Partners -
CID Capital Indiana, Indianapolis, United States
Haitong Innovation Capital Management -
Handelsbanken Stockholm, Stockholm County, Sweden
Hongfu Group -
Incubio Barcelona, Catalonia, Spain
Korea Venture Investment Corp Seoul, Seoul-t'ukpyolsi, South Korea
Lichter Investments -
Next Wave/Portfolia Angel Fund Colorado, Mancos, United States
Ontario Ministry of Economic Development Canada, Ontario, Toronto
Sageview Capital California, Palo Alto, United States
Schmidt Family Foundation -
Shenzhen Capital Fortune Investment Management China, Guangdong, Shenzhen
Shidu Zichan Beijing, China, Haidian
Steinmetz Diamonds New York, New York, United States
The Chinese Founders Fund Beijing, Beijing, China
Zhejiang Xianju Pharmaceutical China, Jiangsu, Taizhou

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Axuall

Health Care
Information and Communications Technology (ICT)
Information Technology
$10M01 Jul 2021 Cleveland, Ohio, United States

SomaLogic

Biotechnology
Health Care
Health Diagnostics
Life Science
Medical Device
Pharmaceutical
$81M23 Dec 2020 Boulder, Colorado, United States

GYANT

Artificial Intelligence
Health Care
Personal Health
$13M15 Jul 2020 San Francisco, California, United States

Syapse

Big Data
Bioinformatics
Cloud Computing
Health Care
Information Services
Information Technology
SaaS
$30M28 May 2020 San Francisco, California, United States

Omada Health

Health Care
Medical
Therapeutics
Wellness
10 Oct 2019 San Francisco, California, United States
News
Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama

– Saama technologies announced a strategic growth investment and will be acquired by Carlyle.
– Saama’s intelligent Life Science Analytics Cloud (LSAC) is used by over 50 pharma and biotech companies on more than 1,500 studies.
– As an end-to-end platform, LSAC provides a unified approach to clinical trial data management and analytics.
– Carlyle has made a strategic growth investment and will acquire a majority stake in the Company.
– A broad co-investor group with several healthcare-focused venture funds, including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners, will be investing alongside Carlyle.

Axuall Closes $10.4 Million Series A Financing Led by Flare Capital Partners

– Axuall, a digital professional identity network that enables healthcare providers to share their authenticated credentials and qualifications in real-time, announced that they closed $10.4m in Series A funding led by Flare Capital Partners.
– The round was led by Flare Capital Partners and includes participation from the company’s executive leadership, Intermountain Ventures, University Hospitals Ventures, MedStar Health, Epsilon Health, InHealth Ventures, AV8 Ventures, JumpStart, M25 Ventures, and North Coast Ventures.
– Capital from this financing will be used to accelerate R&D, implementations, sales, and marketing as the company grows its customer base of healthcare organizations.
– “Led by Flare Capital Partners and representing over two dozen healthcare organizations, this financing represents a ringing endorsement from the healthcare community,” said Axuall’s CEO, Charlie Lougheed.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Intermountain Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: